Clinical Trials Browser

Phase 1/2 × HBI-8000 × Gastrointestinal × Clear all

NCT05770882 2025-03-11

Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC)

Phase 1/2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular